Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Cash from Financing Activities (2018 - 2025)

Profound Medical has reported Cash from Financing Activities over the past 8 years, most recently at $41.4 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 16.91% year-over-year to $41.4 million; the TTM value through Dec 2025 reached $41.1 million, down 24.79%, while the annual FY2025 figure was $41.1 million, 24.79% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $41.4 million at Profound Medical, up from -$290000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $41.4 million in Q4 2025 and troughed at -$603000.0 in Q2 2024.
  • A 5-year average of $6.5 million and a median of $89000.0 in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 312.36% in 2023 and later surged 17906.53% in 2024.
  • Year by year, Cash from Financing Activities stood at -$88000.0 in 2021, then surged by 8063.64% to $7.0 million in 2022, then plummeted by 102.84% to -$199000.0 in 2023, then surged by 17906.53% to $35.4 million in 2024, then grew by 16.91% to $41.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for PROF at $41.4 million in Q4 2025, -$290000.0 in Q1 2025, and $35.4 million in Q4 2024.